Proposals for leflunomide use to avoid lung injury in patients with rheumatoid arthritis
暂无分享,去创建一个
Y. Saeki | T. Sawada | T. Takeuchi | S. Inokuma | T. Takemura | A. Sagawa | T. Matsuda | Takeo Sato | T. Ohtsuka
[1] Y. Kohno,et al. Methotrexate-induced lung injury in patients with rheumatoid arthritis occurs with peripheral blood lymphocyte count decrease , 2006, Annals of the rheumatic diseases.
[2] J. McCurry. Japan deaths spark concerns over arthritis drug , 2004, The Lancet.
[3] B. Jarvis,et al. Leflunomide , 1999, Drugs.
[4] V. Strand,et al. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. , 1999, Archives of internal medicine.
[5] J. Smolen,et al. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial , 1999, The Lancet.
[6] B. Rozman. Clinical experience with leflunomide in rheumatoid arthritis. Leflunomide Investigators' Group. , 1998, The Journal of rheumatology. Supplement.
[7] N. Kobayashi,et al. Leflunomide-induced pneumonitis in a patient with rheumatoid arthritis. , 2006, Internal medicine.
[8] B. Rozman. Clinical experience with leflunomide in rheumatoid arthritis , 1998 .